MRC Technology appoints two new members to its board of trustees
7 April 2016 | By Victoria White, Digital Content Producer
MRC Technology has appointed Dr Les Hughes and Dr Mike Romanos to the board of trustees, effective 1 March 2016...
List view / Grid view
News
Allergan signs $3.35 billion Alzheimer’s treatment deal with Heptares
7 April 2016 | By Victoria White, Digital Content Producer
Allergan is to license exclusive global rights to a broad portfolio of novel subtype-selective muscarinic receptor agonists in development by Heptares...
MRC Technology and IPS-CAS in antibody drug discovery collaboration
6 April 2016 | By Victoria White
The parties created IPS-MRCT Joint Centre for Therapeutic Antibodies in order to combine their expertise in research and development...
Allergan and Pfizer terminate merger agreement
6 April 2016 | By Victoria White
The decision was driven by the actions announced by the US Department of Treasury to reform inversion tax rules, which the companies concluded qualified as an “Adverse Tax Law Change”. Market rumour suggests that Pfizer will now target Shire or AstraZeneca and shares in both companies went up with the…
First glimpse of an immature HIV-neutralising antibody
6 April 2016 | By Victoria White
Scientists have described the first-ever immature antibody found in a powerful class of immune molecules effective against HIV. TSRI biologist Jiang Zhu called the antibody a “teenager” and said it gives scientists a unique view of the steps needed to prompt the immune system to effectively target HIV...
TSRI scientists get grant to develop treatments for addiction and mood disorders
6 April 2016 | By Victoria White
Laura Bohn, principal investigator of the project, will focus on the kappa opioid receptor, which helps regulate the release of dopamine...
New mouse model for Zika to aid vaccine research
5 April 2016 | By Victoria White
The mouse model of Zika mimics aspects of the infection in humans, with high levels of the virus seen in the mouse brain and spinal cord...
New method inhibits the growth of TB causing bacteria
5 April 2016 | By Victoria White
A research team investigated the impact of compounds related to cholesterol on the TB causing bacterium Mycobacterium tuberculosis...
NIAID awards $3.1m in grants for research into vaccine adjuvants
5 April 2016 | By Victoria White
Research will include studies into how combinations of adjuvants interact with the immune system, and how synergies between adjuvants can be optimised...
Astellas and AIST enter Chagas’ disease collaboration
1 April 2016 | By Victoria White
Astellas and AIST aim to discover new drugs using genome editing technology and a high throughput activity assay for Trypanosoma cruzi...
Prosthetic ovary implant restores fertility in mice
1 April 2016 | By Victoria White
Researchers hope to use the technology to develop an ovary bioprosthesis that could be implanted in women to restore fertility...
Zika virus structure revealed by Purdue scientists
1 April 2016 | By Victoria White
Researchers have determined the structure of the Zika virus, revealing insights critical to the development of effective antiviral treatments and vaccines...
Commense advances childhood health microbiome platform
31 March 2016 | By Victoria White
Commense has advanced its development platform, named its founding scientists and advisors, and executed an exclusive license in the microbiome field...
Children with cancer to be offered gene testing in personalised treatment initiative
31 March 2016 | By Victoria White
Children with cancer will be offered testing for genetic mutations in their tumours as part of an initiative to personalise children’s cancer treatment...
New AML mouse model opens door to new treatments
30 March 2016 | By Victoria White
Scientists from Cincinnati Children's Hospital Medical Centre have already used it to identify promising drug targets for acute myeloid leukaemia (AML)...
